Flourish Research San Antonio (Clinical Trials of Texas)
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wilson, Sierra
NCT06532942: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers

Recruiting
1
40
US
(Part A) MKND-201, Placebo, (Part B) MKND-201
Mannkind Corporation
Healthy Volunteers
10/24
10/24
NCT06799013: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Not yet recruiting
1
48
US
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321
HDT Bio, DFNet Research Inc., Technical Resources International, Inc. (TRI), BioAgilytix Labs, LLC, The University of Texas Medical Branch, Galveston, Clinical Trials of Texas, Inc., Quest Laboratories
Vaccine, Crimean-Congo Hemorrhagic Fever
12/26
07/27
Duthie, Malcolm
NCT06799013: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Not yet recruiting
1
48
US
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321
HDT Bio, DFNet Research Inc., Technical Resources International, Inc. (TRI), BioAgilytix Labs, LLC, The University of Texas Medical Branch, Galveston, Clinical Trials of Texas, Inc., Quest Laboratories
Vaccine, Crimean-Congo Hemorrhagic Fever
12/26
07/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wilson, Sierra
NCT06532942: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers

Recruiting
1
40
US
(Part A) MKND-201, Placebo, (Part B) MKND-201
Mannkind Corporation
Healthy Volunteers
10/24
10/24
NCT06799013: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Not yet recruiting
1
48
US
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321
HDT Bio, DFNet Research Inc., Technical Resources International, Inc. (TRI), BioAgilytix Labs, LLC, The University of Texas Medical Branch, Galveston, Clinical Trials of Texas, Inc., Quest Laboratories
Vaccine, Crimean-Congo Hemorrhagic Fever
12/26
07/27
Duthie, Malcolm
NCT06799013: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Not yet recruiting
1
48
US
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321
HDT Bio, DFNet Research Inc., Technical Resources International, Inc. (TRI), BioAgilytix Labs, LLC, The University of Texas Medical Branch, Galveston, Clinical Trials of Texas, Inc., Quest Laboratories
Vaccine, Crimean-Congo Hemorrhagic Fever
12/26
07/27

Download Options